Innovative dressing and securement of tunneled central venous access devices in pediatrics: A pilot randomized controlled trial

BMC Cancer

Volumn 17, Issue 1, 2017, Pages

  Ullman, Amanda J ^a,b   Kleidon, Tricia ^b,c   Gibson, Victoria ^b,c   McBride, Craig A ^a,b,d   Mihala, Gabor ^a,b   Cooke, Marie ^a,b   Rickard, Claire M ^a,b  

^a GRIFFITH UNIVERSITY   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

^c LADY CILENTO CHILDREN S HOSPITAL   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Central venous catheter; Dressing; Evidence based care; Pediatrics; Randomized controlled trial

Indexed keywords

ENBUCRILATE; POLYURETHAN;

ADOLESCENT; ARTICLE; AUSTRALIA; BLOODSTREAM INFECTION; CENTRAL VENOUS ACCESS DEVICE; CHILD; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DEVICE FAILURE; DEVICE MIGRATION; FEASIBILITY STUDY; FEMALE; FOAM DRESSING; HUMAN; MALE; MEDICAL DEVICE; MEDICAL DEVICE COMPLICATION; OCCLUSION; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PILOT STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SECUREMENT DRESSING; SURGICAL MESH; SUTURELESS SECUREMENT DEVICE; VASCULAR ACCESS DEVICE; WOUND DRESSING; BANDAGE; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CHEMISTRY; CLINICAL TRIAL; INFANT; PATHOPHYSIOLOGY; PRESCHOOL CHILD; VEIN;

AUSTRALIA; BANDAGES; CATHETER-RELATED INFECTIONS; CENTRAL VENOUS CATHETERS; CHILD; CHILD, PRESCHOOL; EQUIPMENT FAILURE; FEASIBILITY STUDIES; FEMALE; HUMANS; INFANT; MALE; PILOT PROJECTS; POLYURETHANES; VEINS;

EID: 85028507744     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/s12885-017-3606-9     Document Type: Article

References (50)

1. Chopra V, Flanders SA, Saint S, Woller SC, O'Grady NP, Safdar N, Trerotola SO, Saran R, Moureau N, Wiseman S, et al. The Michigan Appropriateness Guide for Intravenous Catheters (MAGIC): Results From a Multispecialty Panel Using the RAND/UCLA Appropriateness Method. Ann Intern Med. 2015;163(6 Suppl):S1-S40.
2. Robinson JL, Casey LM, Huynh HQ, Spady DW. Prospective cohort study of the outcome of and risk factors for intravascular catheter-related bloodstream infections in children with intestinal failure. J Parenter Enteral Nutr. 2013;35(5):625-30.
3. Fratino G, Molinari AC, Parodi S, Longo S, Saracco P, Castagnola E, Haupt R. Central venous catheter-related complications in children with oncological/hematological diseases: an observational study of 418 devices. Annals of oncology: Official J Eur Soc Med Oncol / ESMO. 2005;16(4):648-54.
4. Barnacle A, Arthurs OJ, Roebuck D, Hiorns MP. Malfunctioning central venous catheters in children: a diagnostic approach. Pediat Radiol. 2008;38(4):363-78. quiz 486-367
5. O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, O'Heard S, Lipsett PA, Masur H, Mermel LA, Pearson ML, et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis. 2011;52(9):e162-93.
6. Ullman AJ, Marsh N, Mihala G, Cooke M, Rickard C. M.: Complications of central venous access devices: a systematic review. Pediatrics. 2015;136(5):e1331-44.
7. Ullman AJ, Cooke M, Rickard C. Examining the role of securement and dressing products to prevent central venous access device failure: a narrative review. J Assoc Vasc Access. 2015;20(2):99-110.
8. Webster J, Gillies D, O'Riordan E, Sherriff KL, Rickard CM. Gauze and tape and transparent polyurethane dressings for central venous catheters (review). Cochrane Database Syst Rev. 2011;11:1-35.
9. Ullman AJ, Cooke ML, Mitchell M, Lin F, New K, Long DA, Mihala G, Rickard CM. Dressings and securement devices for central venous catheters (CVC). Cochrane Database Syst Rev. 2015;9:Cd010367.
10. Brandt B, DePalma J, Irwin M, Shogan J, Lucke JF. Comparison of central venous catheter dressings in bone marrow transplant recipients. Oncol Nursing Forum. 1996;23(5):829-36.
11. Shivnan JC, McGuire D, Freedman S, Sharkazy E, Bosserman G, Larson E, Grouleff P. A comparison of transparent adherant and dry sterile guaze dressings for long-term central catheters in patients undergoing bone marrow transplant. Oncol Nursing Forum. 1991;18(8):1349-56.
12. Chambers ST, Sanders J, Patton WN, Ganly P, Birch M, Crump JA, Spearing RL. Reduction of exit-site infections of tunnelled intravascular catheters among neutropenic patients by sustained-release chlorhexidine dressings: results from a prospective randomized controlled trial. J Hosp Infect. 2005;61(1):53-61.
13. Olson R, RP HJ, Ryan M, Gilpin J, Falsetti M, Heffner T, Gaudet S. Evaluation of a no-dressing intervention for tunneled central venous catheter exit sites. J Infus Nurs. 2004;27(1):37-44.
14. Ruschulte H, Franke M, Gastmeier P, Zenz S, Mahr K, Bucholz S, Hertenstein B, Hecker H, Piepenbrock S. Prevention of central venous catheter related infections with chlorhexidine gluconate impregnated wound dressings: a randomized controlled trial. Ann Hematol. 2009;88:267-72.
15. Harron K, Ramachandra G, Mok Q, Gilbert R. On behalf of the CATCH team: Consistency between guidelines and reported practice for reducing the risk of catheter-related infection in British paediatric intensive care units. Intensive Care Med. 2011;37:1641-7.
16. Yamamoto A, Solomon J, Soulen M, Tang J, Parkinson K, Lin R, Schears G. Sutureless securement device reduces complications of peripherally inserted central venous catheters. J Vascul Int Radiol: JVIR. 2002;13(1):77-81.
17. Wilkinson JN, Sheikh N, Jayamaha J. Tissue adhesive as an alternative to sutures for securing central venous catheters. Anaesthesia. 2007;62(9):969-70.
18. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. 2008;337:a1655.
19. Ullman AJ, Kleidon T, Gibson V, Long DA, Williams T, McBride CA, Hallahan A, Mihala G, Cooke M, Rickard CM. Central venous Access device SeCurement And Dressing Effectiveness (CASCADE) in paediatrics: protocol for pilot randomised controlled trials. BMJ Open. 2016;6(6)
20. Julious SA. Sample size of 12 per group rule of thumb for a pilot study. Pharmaceutical Stat. 2005;4:287-97.
21. Hertzog M. Considerations in determining sample size for pilot studies. Res Nurs Health. 2008;31:180-91.
22. Lancaster GA, Dodd S, Williamson PR. Design and analysis of pilot studies: recommendations for good practice. J Eval Clin Pract. 2004;10(2):307-12.
23. Thabane L, Ma J, Chu R, Cheng J, Ismaila A, Rios LP, Robson R, Thabane M, Giangregorio L, Goldsmith CH. A tutorial on pilot studies: the what, why and how. BMC Med Res Meth. 2010;10(1):1.
24. Centers for Disease Control and Prevention. National Healthcare Safety Network Device Associated Module: CLABSI. Atlanta: Edited by Government USoA; 2014. p. 1-9.
25. Fratino G, Avanzini S, Molinari AC, Buffa P, Castagnola E, Haupt R. Incidence of indwelling central venous catheter-related complications using the Sri Paran technique for device fixation in children with cancer. Pediat Surg Int. 2009;25(7):591-4.
26. Broadhurst D, Moureau N, Ullman AJ. Central venous access devices site care practices: an international survey of 34 countries. J Vasc Access. 2015;0(0):0.
27. Cecinati V, Brescia L, Tagliaferri L, Giordano P, Esposito S. Catheter-related infections in pediatric patients with cancer. Eur J Clin Microbiol Infect Dis: Off Pub Eur Soc Clin Microbiol. 2012;31(11):2869-77.
28. Reichman D, Greenberg J. Reducing surgical site infections: a review. Rev Obst Gyn. 2009;2(4):212-21.
29. Advani S, Reich NG, Sengupta A, Gosey L, Milstone AM. Central line-associated bloodstream infection in hospitalized children with peripherally inserted central venous catheters: extending risk analyses outside the intensive care unit. Clin Infect Dis. 2011;52(9):1108-15.
30. Lorente L, Huidobro MS, Martin MM, Jimenez A, Mora ML. Accidental catheter removal in critically ill patients: a prospective and observational study. Crit Care. 2004;8(4):R229-33.
31. Jumani K, Advani S, Reich NG, Gosey L, Milstone AM. Risk factors for peripherally inserted central venous catheter complications in children. JAMA Pediat. 2013;167(5):429-35.
32. Centre for Healthcare Related Infection Surveillance and Prevention & Tuberculosis Control: Guideline: Tunnelled Central Venous Catheter. In. Edited by Health Do, version 2 edn. Brisbane: Queensland Government; 2013.
33. Children's Health Services. In: Health Q, editor. Central venous catheters: nursing care and management of tunnelled (cuffed and non-cuffed) CVC in paediatric patients. 1st ed. Brisbane: Queensland Government; 2011.
34. Children's Health Services. CVAD Insertion and Management. Brisbane: Queensland Government; 2014.
35. Frasca D, Dahyot-Fizelier C, Mimoz O. Prevention of central venous catheter-related infection in the intensive care unit. Critical Care. 2010;14(212) doi: 10.1186/cc8853.
36. Maki DG, Kluger DM, Crnich CJ. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc. 2006;81(9):1159-71.
37. Rickard CM, Marsh NM, Webster J, Gavin NC, McGrail MR, Larsen E, Corley A, Long D, Gowardman JR, Murgo M, et al. Intravascular device administration sets: replacement after standard versus prolonged use in hospitalised patients-a study protocol for a randomised controlled trial (The RSVP Trial). BMJ Open. 2015;5(2):e007257.
38. Rothwell PM. Factors that can affect the external validity of randomised controlled trials. PLoS clinical trials. 2006;1(1):e9.
39. StataCorp. Stata Statistical Software: Release 12.1. College Station: StataCorp LP; 2014.
40. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010;152(11):726-32.
41. Timsit JF, Bouadma L, Ruckly S, Schwebel C, Garrouste-Orgeas M, Bronchard R, Calvino-Gunther S, Laupland K, Adrie C, Thuong M, et al. Dressing disruption is a major risk factor for catheter-related infections. Crit Care Med. 2012;40(6):1707-14.
42. Goudie A, Dynan L, Brady PW, Rettiganti M. Attributable cost and length of stay for central line-associated bloodstream infections. Pediatrics. 2014;133(6):e1525-32.
43. Wilson MZ, Rafferty C, Deeter D, Comito MA, Hollenbeak CS. Attributable costs of central line-associated bloodstream infections in a pediatric hematology/oncology population. Am J Infect Control. 2014;42(11):1157-60.
44. Thayer D. Skin damage associated with intravenous therapy: common problems and strategies for prevention. J Infus Nurs. 2012;35(6):390-401.
45. Wall JB, Divito SJ, Talbot SG. Chlorhexidine gluconate-impregnated central-line dressings and necrosis in complicated skin disorder patients. J Crit Care. 2014;29(6):1130.e1131-4.
46. McNichol L, Lund C, Rosen T, Gray M. Medical adhesives and patient safety: state of the science: consensus statements for the assessment, prevention, and treatment of adhesive-related skin injuries. Orthopedic Nurs. 2013;32(5):267-81.
47. Kutzscher L. Management of irritant contact dermatitis and peripherally inserted central catheters. Clin J Oncol Nurs. 2012;16(2):E48-55.
48. LeBlanc K, Baranoski S. Skin tears: state of the science: consensus statements for the prevention, prediction, assessment, and treatment of skin tears (c). Advances Skin Wound Care. 2011;24(9 Suppl):2-15.
49. Levy I, Katz J, Solter E, Samra Z, Vidne B, Birk E, Ashkenazi S, Dagan O. Chlorhexidine-impregnated dressing for prevention of colonization of central venous catheters in infants and children: a randomized controlled study. Pediatr Infect Dis J. 2005;4(8):676-9.
50. Hill ML, Baldwin L, Slaughter JC, Walsh WF, Weitkamp JH. A silver-alginate-coated dressing to reduce peripherally inserted central catheter (PICC) infections in NICU patients: a pilot randomized controlled trial. J Perinatol: Off J California Perinatal Assoc. 2010;30(7):469-73.